L
LifeX
A platform by which we create the world where all mankind is free from disease
About LifeX
LifeX, formerly Humanscape, is a health-tech company that operates a blockchain-based platform for collecting and managing patient health data, with a specific focus on rare and incurable diseases. The company aims to improve the chances of cure for patients by creating a network where they can share their health information in a secure and transparent way.
The platform connects patients with pharmaceutical companies, research institutions, and hospitals, allowing them to utilize the collected data for research and development of new treatments. By leveraging blockchain technology, LifeX ensures the integrity and security of the data, while giving patients control over their information.
The company's business model is based on providing access to its platform and the valuable patient data to its clients, which include pharmaceutical companies and research organizations. This data can help accelerate the development of new therapies and improve the understanding of rare diseases.
LifeX operates in the growing digital health market, with a focus on the niche segment of rare diseases. The company has a strong presence in South Korea and is expanding its operations globally.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Seoul, South Korea
- Employees
- 68
- Open positions
- None listed
- Dealroom signal
- 75.4/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Pregnancy, Patient Engagement, Medical Data, Health Diagnostics
- Technology
- Blockchain, Artificial Intelligence, Natural Language Processing, Computer Vision, Mobile app
- Business model
- SaaS
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Dec 2025 | $4.2M | $84M | Undisclosed | ↗ |
| SERIES COther financing | Dec 2023 | $17M | $67M | Industrial Bank of Korea · Hana Ventures · Hana Securities | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for LifeX is 4.7K monthly website visits, down 70.6% over the last three months. LifeX's team declined 2.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Mashup Ventures
Magellan Technology Investment
Series A5 investors entered at this stage
- PIP&I Investment
Korea Investment Partners
KB Securities
Nau IB Capital- GPGC Pharma
Series B and later11 investors entered at this stage
Kakao Corp
Green Cross
Mint Venture Partners- CLCare Labs
Hana Securities
UTC Investment
Kyobo Securities- SVShinhan Bank Vietnam
Shinhan Asset Management
Industrial Bank of Korea
Hana Ventures
Other known investors1 additional known investor
Google for Startups Accelerator
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about LifeX on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LifeX’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.